Acrylamide is a substance that can be neurotoxic in humans and experimental animals. It is 30 formed at different rates in starchy foods cooked at temperatures above 120°C as a result of 31 interaction between monosaccharides and the amino acid asparagine. Carnosic acid 32 accounts for over 90% of the antioxidant properties of rosemary extract and is a powerful 33 inhibitor of lipid peroxidation in microsomal and liposomal systems. Carnosic acid has been 34 shown to protect against oxidative and inflammatory effects. In order to investigate the 35 protective properties of carnosic acid against acrylamide-induced toxicity in human retinal 36 pigment epithelium (RPE) cells, ARPE-19 cells were pre-treated with 10µM CA for 24h 37 followed by treatment with acrylamide (0.7 or 1 mM) for 24h. ARPE-19 cells pre-treated with 38 10µM carnosic acid showed significantly increased cell viability and decreased cell death rate 39 when compared to ARPE-19 cells treated with acrylamide alone. Activities of SOD and 40 catalase and the level of GSH and expression of NRF2 and a number of anti-oxidant genes 41 were significantly decreased in ARPE-19 cells, while there were significant increases in ROS 42 and MDA; pre-treatment with carnosic acid significantly counteracted these changes. Our 43 results suggest that carnosic acid protected RPE cells from acrylamide-induced toxicity. 44 45 Key words Acrylamide, carnosic acid, neurotoxicity, oxidative damage, retinal pigment 46 epithelium cells 47 48 49 50 51 52 53 54 55 56 (EFSA, 2015). 79
Introduction 57
Acrylamide (Fig. 1E) is a highly water-soluble white substance with a solid crystalline form 58 (Becalski et al., 2003; Exon, 2006) . The main application of acrylamide and polyacrylamides 59 is in the manufacture of plastics and in the welding of waterpipes, although they are also 60 used in the production of paper and textiles. In addition, acrylamide monomer is used in the 61 preparation of polyacrylamide electrophoresis gels in research and clinical diagnosis labs 62 (Dybing et al., 2005) . Acrylamide is also formed in starchy foods such as fried potatoes, 63 bread, cookies, and coffee heated to temperatures above 120°C (Tareke et al., 2002; 64 Kahkeshani et al., 2015) . Generally, the formation of acrylamide during cooking at high 65 temperatures is due to the reaction between the amino acid asparagine and a carbonyl- Rodents with oral exposure to acrylamide experienced tumours in various organs (EFSA, 77 2015) while humans exposed to acrylamide have an increased risk of developing cancer 78 
Materials and methods

Western blotting assay 169
Control and treated ARPE-19 cells were lysed with ice-cold RIPA lysis buffer (Thermo 170 Scientific), the lysates were collected and centrifuged, and the supernatants were stored at 171 -80°C until required. Protein concentration was determined using Precision Red Advanced 172
Protein Assay reagent (Cytoskeleton, Inc. Cat. # ADV02-A) according to the manufacturer's 173 guidelines. Proteins were run in SDS-PAGE and transferred to nitrocellulose membrane 174 (Amersham Biosciences). The membrane was blocked by incubation in 5% milk powder in 175
Tris-Buffered Saline-Tween 20 buffer for 1 hour at room temperature, followed by incubation 176 with primary antibodies (GAPDH and NRF2, 1:1000 dilution) overnight at 4°C. The 177 membrane was washed and incubated with secondary antibodies (1:10000 dilution). The 178 signals were detected using the LI-COR Odyssey FC Imaging System and the signal 179 intensity was analyzed by Image Studio™ Lite analysis software (LI-COR). 180 181
Detection of cell death 182
Cell death was detected using DeadEnd TM fluorometric TUNEL assay kit (Promega) following 183 the manufacturer's instructions. Briefly, treated and control ARPE1-9 cells were fixed with 4% 184 PFA for 20 minutes at 4°C and washed with PBS once, followed by permeabilisation with 185 0.2% Triton X-100 in PBS for 5 min. Cells were labelled with rTDT reaction mix for one hour 186 at 37°C and the reaction was stopped with 2X SSC. Cells were rinsed with PBS and 187 mounted using Vectashield mounting media containing DAPI (Vector laboratories). Images 188 were captured using ZEISS LSM 800 confocal microscopy. To quantify cell death, the 189 number of TUNEL positive cells in 300 cells was counted from three individual samples (100 190 cells in each sample). 191 192
Statistical Analysis 193
Statistical analysis was carried out using GraphPad Prism 6 software. All data were obtained 194 from three independent experiments using one-way ANOVA test. Data are presented as
Acrylamide treatment resulted in decreased RPE cell viability that was 198 significantly counteracted by carnosic acid 199
To investigate the effect of acrylamide-induced toxicity in RPE cells, cell viability was 200 assessed by crystal violet staining ( Fig. 1D ). Cell viability of ARPE-19 cells was significantly 201 decreased to 65.55%, 50.05%, and 36.37% of untreated levels following exposure to 0.7, 202 1.0, or 2.0mM acrylamide respectively ( Fig. 1A) . ARPE-19 exposed to acrylamide at 0.37 203 and 0.5mM showed no significant reduction in cell viability. Prior to investigating the 204 protective effect of carnosic acid on acrylamide exposure, we assessed cell viability of 205 ARPE-19 cells treated with carnosic acid at 10, 20, 30, 40, 50, and 60µM and found that cell 206 viability was significantly decreased when treated with carnosic acid of 40, 50 or 60µM but 207
was not significantly changed when treated with carnosic acid at 10, 20 or 30µM ( Fig. 1B) . 208
Consequently, acrylamide at concentrations of 0.7 and 1.0mM and carnosic acid at 209 concentration of 10µM were used for subsequent experiments. ARPE-19 cells first treated 210 with carnosic acid (10µM) for 24 h and then exposed to 0.7 or 1mM acrylamide for 24 h 211 demonstrated significantly increased cell viability by 12.21% and 14.25% respectively when 212 compared with cells treated with acrylamide alone ( Fig. 1 C, D) . 213 214
Carnosic acid protects against acrylamide-induced cell death in RPE cells 215
We examined whether reduced cell viability is associated with apoptotic cell death. We used 216 TUNEL staining to assess the cell death ( Fig. 2A ) and found that there was a significantly 217 increased cell death rate in ARPE-19 cells exposed to 0.7 and 1mM acrylamide when 218 compared to untreated control cells and that pre-treatment with carnosic acid led to 219 significant reduction in cell death induced by acrylamide ( Fig. 2B) . 220 of caspase-3 and caspase-9 was significantly decreased in ARPE-19 cells pre-treated with 224 carnosic acid (10µM) when compared to cells treated with acrylamide alone (Fig. 3) . We investigated whether acrylamide treatment can increase intracellular ROS in ARPE-19 229 cells. As shown in Fig. 4 , cells treated with 0.7mM and 1mM acrylamide exhibited notably 230 increased ROS by 32.02% and 34.83% respectively compared with untreated control cells. 231
Cells pre-treated with carnosic acid (10µM) then treated with acrylamide (0.7 and 1mM) 232 showed significantly reduced ROS by 15.02% and 17.33% respectively when compared with 233 cells treated with acrylamide alone. 234 235
Carnosic acid treatment reverses acrylamide-induced changes in the expression of 236 antioxidant genes 237
Acrylamide-induced ROS production is possibly due to cellular antioxidant imbalance, so we 238 examined expression of antioxidant genes in ARPE-19 cells exposed to acrylamide. We 239 found expression of antioxidant genes was decreased in acrylamide-treated cells compared 240 to untreated cells ( Fig. 5 ). Compared to the control group, expression of SOD1 gene was 241 decreased by 50.24% following 0.7mM acrylamide treatment and by 56.58% following 1mM 242 acrylamide treatment; GPX1 gene expression was decreased by 29.47% and 37.66% 243 respectively; CAT gene expression was decreased by 47.80% and 52.27% respectively; 244 NQO-1 gene expression was decreased by 33.67% and 53.04% respectively (although in the 245 former case the difference was not statistically significant); and GCLM gene expression was 246 decreased by 27.34% and 36.31% respectively (although in both cases the difference was 247 not statistically significant). ARPE-19 cells pre-treated with carnosic acid (10µM) showed 248 notably increased expression of these genes compared to cells treated with acrylamide 249 alone: SOD1 expression was increased by 542.6% (pre-treatment with carnosic acid 250 followed by treatment with acrylamide (0.7mM)) and 577.84% (pre-treatment with carnosic acid followed by treatment with acrylamide (1.0mM)); GPX1 expression was increased by 252 384.2% and 304.13% respectively; CAT expression was increased by 457.66% and 418.39% 253 respectively; NQO-1 expression was increased by 352.93% and 429.3% respectively; and 254 GCLM expression was increased by 343.1% and 353.27% respectively (Fig.5) . 255
We also investigated the effects of carnosic acid on SOD and CAT activities. As shown in 256 Fig. 6 , ARPE-19 cells treated with acrylamide at 0.7 or 1.0mM had SOD activities that were 257 significantly reduced by 60.75% and 82.26% respectively, and for CAT by 23.86% and 258 48.6% respectively, when compared to untreated control cells. Pre-treatment with carnosic 259 acid at 10µM resulted in significantly increased activities of SOD by 512.1% following 260 treatment with acrylamide (0.7mM) and by 665.35% following treatment with acrylamide 261
(1.0mM) and increased activity of CAT by 33.68% and 19.49% respectively, when compared 262 to cells treated with acrylamide alone ( Fig. 6A and B) . solely with acrylamide ( Fig. 7B ). Secondly we examined NRF2 protein level by western 291 blotting using anti-NRF2 antibody (Fig. 7C ) and found the level of NRF2 protein was 292 significantly decreased by 65.15% and 82.68% in ARPE-19 cells treated with acrylamide at 293 0.7 and 1.0mM respectively, when compared to untreated control cells. ARPE-19 cells, pre-294 treated with carnosic acid (10 µM) and then treated with acrylamide (0.7 or 1.0mM), had a 295 significant increase in NRF2 protein by 423.33% and 629.21% respectively, compared to 296 cells treated solely with acrylamide ( Fig. 7D) . 297 298
Discussion 299
Humans can be chronically exposed to acrylamide through the intake of certain foods (such 300 as bread, cereals, potato chips and crisps, and coffee) cooked or heated at high 301 temperatures. Workers exposed occupationally to acrylamide exhibited peripheral and 302 central neuropathies (Pennisi et al., 2013) . Tunnel workers exposed to N- . Our results also demonstrated that 323 acrylamide exposure resulted in dose-dependent decreased cell viability ( Fig. 1A) and 324 increased ROS production ( Fig. 4) . Acrylamide-induced cell death was thought to be 325 caspase-3 dependent; elevated caspase-3 activities have been reported in acrylamide-326 
cells. 333
Increased ROS production in acrylamide-exposed cells is due to the disruption of redox 2015; Pan et al, 2016) . We too found that RPE cells exposed to acrylamide had notably 340 decreased GSH and antioxidant enzyme (SOD and catalase) activities, and MDA was also 341 significantly increased (Fig. 6 ), suggesting acrylamide treatment caused the redox imbalance 342 in RPE cells. reversed this effect (Fig. 7) . Acrylamide exposure also downregulated the expression of 355 NFR-targeting antioxidant genes (SOD1, GPX1, catalase, NQO1 and GCLM) (Fig. 5) ; again, 356 carnosic acid treatment was able to reverse these effects. 357
In summary, our results suggest that carnosic acid can protect RPE cells from 358 acrylamide-induced oxidative damages through NRF2 signalling pathway and has a potential 359 for neuroprotection against acrylamide-induced retinal toxicity in humans. 
